Sanofi SA (NASDAQ:SNY)
| 52.44 Delayed Data As of Sep 18 |  +0.37 / +0.71%Today’s Change | 37.62 Today|||52-Week Range 55.00 | +4.46% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2015 | Quarter 3 2015 | Quarter 4 2015 | Quarter 1 2016 | |||
| Operating Activities | Net Income / Starting Line | -- | -- | 4.7B | -- | |
| Depreciation | -- | -- | 4.7B | -- | ||
| Total Other Cash Flow | -- | -- | 612.5M | -- | ||
| Funds From Operations | -- | -- | 8.7B | -- | ||
| Funds From/For Other Operating Expenses | -- | -- | -1.2B | -- | ||
| Net Cash Flow - Operating Activities | -- | -- | 9.8B | -- | ||
| Investing | Increase In Investments | -- | -- | -156.7M | -- | |
| Capital Expenditures | -346.5M | -380.9M | -1.9B | -358.4M | ||
| Fixed Asset Disposal | -- | -- | 232.9M | -- | ||
| Net Assets From Acquisitions | -- | -- | -251.6M | -- | ||
| Other Investing - Uses | -- | -- | -368.6M | -- | ||
| Net Cash Flow Investing | -346.5M | -380.9M | -3.6B | -358.4M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | -219.6M | 0.00 | |
| Long Term Borrowings | 0.00 | 0.00 | 2.5B | 0.00 | ||
| Long Term Debt Reduction | 0.00 | 0.00 | -781.4M | 0.00 | ||
| Net Proceeds Stock Sale | -- | -- | 633.5M | -- | ||
| Common Preferred Redeemed | -- | -- | -2.0B | -- | ||
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | -- | -- | -4.1B | -- | ||
| Other Sources - Financing | -- | -- | 0.00 | -- | -- | |
| Other Uses - Financing | -- | -- | 38.6M | -- | ||
| Net Cash Flow - Financing | 0.00 | 0.00 | -4.0B | 0.00 | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -256.0M | -- | |
| Net Change In Cash | -346.5M | -380.9M | 2.3B | -358.4M | ||
